Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 39
- Medical
Cannabinoids for glioblastoma: MGC Pharma announces pre-clinical trial results
MGC Pharmaceuticals has collaborated with the National Institute of Biology in Slovenia to carry out a three year pre-clinical in vitro research into the use of cannabinoids in the treatment of glioblastoma.
- Cultivation
MoU to establish medical cannabis production facility
The site will be based in Madrid, Spain.
- Data & Analysis
Collaboration to conduct research to support the cannabis industry
Open Book Extracts and Biopharmaceutical Research Company will research the full range of cannabinoids.
- Medical
Materia completes first export to Germany from Malta
Materia Malta is the first company to export medical cannabis from Malta for sale in another country.
- Uncategorized
Deutschland beginnt mit Konsultationen zur Legalisierung von Cannabis
Im Laufe des Jahres 2022 sind Anhörungen geplant, um den neuen Ansatz des Landes bei der Cannabisgesetzgebung zu diskutieren.
- Adult-Use
Germany to begins consultations for cannabis legalisation
Hearings are planned throughout 2022 to discuss the country’s new approach to cannabis legislation.
- Adult-Use
Luxembourg moves forward with bill for cannabis legalisation
State control with product and quality assurance will be introduced under the bill.
- Medical
Ukraine could legalise cannabis in light of impact of Russian war
The move will enable medical cannabis treatment for PTSD obtained as a result of the war and will provide treatment for cancer patients.
- CBD Market
EFSA puts CBD Novel Foods evaluations on hold due to lack of data
Although applications have been put on hold, the EFSA has stated that it has not yet not concluded that CBD is unsafe as a food product.
- Medical
Partnership to increase distribution of cannabis products in Germany
Cantourage and Clever Leaves have intensified their strategic partnership in the country.
- Uncategorized
Partnerschaft zur Steigerung des Vertriebs von Cannabisprodukten in Deutschland
Cantourage und Clever Leaves haben ihre strategische Partnerschaft in diesem Land intensiviert.
- Adult-Use
Thailand becomes first country in Asia to decriminalise cannabis
Under the new law change, people incarcerated on cannabis-related charges will be released from prison.
